Article
A galactose-1-phosphate uridylyltransferase-null rat model of classic galactosemia mimics relevant patient outcomes and reveals tissue-specific and longitudinal differences in galactose metabolism.
Journal of inherited metabolic disease - 1 May 2020
Rasmussen Shauna A, Daenzer Jennifer M I, MacWilliams Jessica A, Head S Taylor, Williams Martine B, Geurts Aron M, Schroeder Jason P, Weinshenker David, Fridovich-Keil Judith L
Abstract excerpt
Classic galactosemia (CG) is a potentially lethal inborn error of metabolism, if untreated, that results from profound deficiency of galactose-1-phosphate uridylyltransferase (GALT), the middle enzyme of the Leloir pathway of galactose metabolism. While newborn screening and rapid dietary restriction of galactose prevent or resolve the potentially lethal acute symptoms of CG, by mid-childhood, most treated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
